Kristoffer Haurum Johansen (Kristoffer H Johansen)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Neoadjuvant Chemotherapy

Top Venues

Science signaling

DNA and cell biology

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Hazel Stewart, Roberta Palmulli, Kristoffer Haurum Johansen, Naomi McGovern, Ola M Shehata, George W Carnell, Hannah K Jackson, Jin S Lee, Jonathan C Brown, Thomas Burgoyne, Jonathan L Heeney, Klaus Okkenhaug, Andrew E Firth, Andrew A Peden, James R Edgar
Tetherin antagonism by SARS-CoV-2 ORF3a and spike protein enhances virus release. EMBO reports (2023)
Kristoffer Haurum Johansen, Dominic P Golec, Bonnie Huang, Chung Park, Julie H Thomsen, Silvia Preite, Jennifer L Cannons, Fabien Garçon, Edward C Schrom, Christina J F Courreges, Tibor Z Veres, James Harrison, Meritxell Nus, James D Phelan, Wolfgang Bergmeier, John H Kehrl, Klaus Okkenhaug, Pamela L Schwartzberg
A CRISPR screen targeting PI3K effectors identifies RASA3 as a negative regulator of LFA-1-mediated adhesion in T cells. Science signaling 15 (743) (2022)
Bonnie Huang, James D Phelan, Silvia Preite, Julio Gomez-Rodriguez, Kristoffer Haurum Johansen, Hirofumi Shibata, Arthur L Shaffer, Qin Xu, Brendan Jeffrey, Martha Kirby, Stacie Anderson, Yandan Yang, Selamawit Gossa, Dorian B McGavern, Louis M Staudt, Pamela L Schwartzberg
In vivo CRISPR screens reveal a HIF-1α-mTOR-network regulates T follicular helper versus Th1 cells. Nature communications 13 (1) (2022)
Kristoffer Haurum Johansen
How CRISPR/Cas9 Gene Editing Is Revolutionizing T Cell Research. DNA and cell biology 41 (1) (2021)